High-tech medical care (HMP)
High-tech medical care (VMP) is provided in the treatment of complex diseases. In such cases, cellular and information technologies, robotic techniques and genetic engineering methods are used. VMP is used in various fields of medicine, including, for example, in hematology, neurosurgery, in the treatment of severe burns, in oncology, neonatal surgery.
Content |
2024: Moscow allocated 2.6 billion rubles for the development of high-tech treatments
The Moscow government has decided to allocate ₽2,6 billion to support the development of innovative treatment methods in the capital's medical institutions. This became known on July 23, 2024 as part of the announcement of a new application campaign for special grants from the mayor of Moscow. Read more here
2023: The Supreme Court of the Russian Federation forbade hospitals to do MRI without referral
The Supreme Court (Supreme Court) of Russia forbade citizens to undergo magnetic resonance imaging (MRI) without the consent of a doctor. The relevant court decision became known in early October 2023. Read more here.
2020: Putin instructed to organize payment for high-tech medical care from the budget
Russia Vladimir Putin The President at the meeting held on August 11, 2020 gave a number of instructions. In Government of the Russian Federation particular, by October 15, the Cabinet of Ministers needs to calculate budget funding for 2021-2023 for the implementation of measures to provide high-tech medical care and medical care for patients, cancer as well as citizens suffering from other rare diseases (including hemophilia, cystic fibrosis, pituitary nanism, Gaucher's disease, etc.).
In addition, at the expense of the federal budget, it is planned to additionally finance the purchase of drugs for patients with malignant formations of lymphoid, hematopoietic and related tissues, multiple sclerosis, hemolytic-uremic syndrome, systemic juvenile arthritis, mucopolysaccharidosis of types I, II and VI, aplastic anemia, hereditary deficiency of factors II (fibrinogen), VII (labile), X (Stuart-Prauer).
By the end of August 2020, the national project "Healthcare" includes the federal projects "Combating Cancer" and "Development of Children's Health," for which the corresponding costs will be spent. In total, until 2024, 1.7 trillion rubles were planned to be spent on healthcare development measures. However, the COVID-19 coronavirus pandemic forced the state to urgently inject funds to re-equip hospitals to combat the new disease and provide doctors with personal protective equipment. At the same time, in the future, the cost of medicine was planned to be cut. The new project budget will be known in the fall of 2020, when Vladimir Putin will be presented with a development plan until 2030.
According to Deputy Prime Minister of the Russian Federation Tatyana Golikova, funding for cancer care, drug provision and high-tech medical care will continue to increase.[1]
Financing of WMP
In 2014, about 50 billion rubles were allocated to finance advanced technologies, in 2015 - already 82 billion, then in 2016 the WMP will "eat" 96.7 billion rubles. insurance money, according to the MHIF budget approved by the State Duma. In addition, VMPs can finance the regions of Russia from their budgets[2].
So, Moscow in 2015, allocates 2.5 billion rubles for these purposes, in 2016 - 5 billion rubles. About 5% of VMP expenditures are allocated directly from the federal budget: 5 billion rubles. provided for co-financing of regional expenditures (30% of the federal budget by 70% of the regional).
For 10 months of 2015, 37.5 thousand Muscovites and 8.1 thousand nonresident people received VMP in the capital, of these 45.5 thousand patients in federal clinics treated 10.8 thousand people - less than a quarter. The rest received the services of Moscow clinics.
MGFOMS paid only 5.1 billion rubles. for VMP (for 10 months of this year). According to the fund's forecast, in general, in 2015, VMP in Moscow will receive about 55 thousand patients, and it will cost 7.4 billion rubles. (including financing from the Moscow budget - 2.5 billion rubles. and from the federal budget under the co-financing program - 0.5 billion rubles).